Article Text

PDF
Proteomic characterisation of pancreatic islet β-cells stimulated with pancreatic carcinoma cell conditioned medium
  1. G Song,
  2. Y Cui,
  3. N Zhong,
  4. J Han
  1. Shandong Medicinal Biotechnology Center, Shandong Academy of Medicinal Sciences, Key Laboratory for Biotech-Drugs Ministry of Health & Key Laboratory for Modern Medicine and Technology of Shandong Province, Jinan, Shandong Province, China
  1. Correspondence to Dr J Han, Shandong Medicinal Biotechnology Center, Shandong Academy of Medicinal Sciences, 89 Jingshi Road, Jinan, Shandong Province, P.R. China; jxhan9888{at}yahoo.com.cn

Abstract

Aim: To characterise the protein expression profiles of pancreatic islet β-cells affected by cancer cells, and to identify the potential islet molecules related to pancreatic cancer-associated diabetes.

Methods: The cellular proteins of islet β-cell line INS-1 in response to conditioned medium (CM) prepared from pancreatic cancer cells were analysed using fluorescence-labelled 2D gel-based proteomics (2D-DIGE).

Results: 10 proteins were over-expressed and five were under-expressed in cancer CM-stimulated β-cells. Five differently expressed proteins were selected for further validation by Western blot analysis. HSP60 and peripherin, which have previously been reported to be associated with type 1 diabetes, and Prp19, a DNA repair protein, were up-regulated in INS-1 cells after cancer cell CM stimulation; HMOX1 and GRP78 were down-regulated. The islets adjacent to human pancreatic carcinomas showed increased peripherin expression than normal pancreatic islets.

Conclusion: These results provide new information regarding the regulation of protein expression in pancreatic cancer-associated diabetes.

Statistics from Altmetric.com

Footnotes

  • Funding This work was supported by Key Project of Department of Science & Technology of Shandong Province, China (No.2005GG1102003).

  • Competing interests None.

  • Provenance and Peer review Not commissioned; externally peer reviewed.

  • Ethics approval Ethics approval was obtained.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.